CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches-Reference-Cited by-同舟云学术

CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches

Published:2024-08 Issue: Volume: Page:101692
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Tang Jiajia,Zheng Quan,Wang Qi,Zhao Yaru,Ananthanarayanan Preeta,Reina Chiara,Šabanović Berina,Jiang Ke,Yang Ming-Hsin,Meny Clara Csilla,Wang Huimin,Agerbaek Mette Ø.,Clausen Thomas Mandel,Gustavsson Tobias,Wen Chenlei,Borghi Felice,Mellano Alfredo,Fenocchio Elisabetta,Gregorc Vanesa,Sapino Anna,Theander Thor G.,Fu Da,Aicher Alexandra,Salanti Ali,Shen Baiyong,Heeschen Christopher^ORCID

Funder

Fondazione AIRC per la ricerca sul cancro ETS

National Natural Science Foundation of China-Yunnan Joint Fund

Erciyes Üniversitesi

Eurostars

Institute for Information Industry, Ministry of Science and Technology, Taiwan

Shanghai Rising-Star Program

Rete Oncologica del Piemonte e della Valle d'Aosta

Seventh Framework Programme

FP7 Space

Shanghai Municipal Population and Family Planning Commission

Publisher

Elsevier BV

Reference51 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

2. Global Burden of 5 Major Types of Gastrointestinal Cancer;Arnold;Gastroenterology,2020

3. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet. Gastroenterol. Hepatol.,2019

4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N. Engl. J. Med.,2011

5. Cancer statistics, 2022;Siegel;CA A Cancer J. Clin.,2022